EOM Pharmaceutical Holdings Inc. (IMUC)

[bob smith]

10-Q Key points.

The Issuer had 40,620,796 shares of its common stock outstanding as of August 10, 2012.


Cash and cash equivalents: $11,339,843 as june 30th 2012
(As of June 30, 2012, we had working capital of $10,936,266 compared to working capital of $4,893,165 as of December 31, 2011)


Legal Proceedings : None.


Liquidity —As of June 30, 2012, the Company had working capital of $10,936,266, compared to working capital of $4,983,165 as of December 31, 2011. The Company believes that its existing cash balances are sufficient for the next twelve months.

As of June 30, 2012 the Company had $598,521 of deposits that were in excess of the FDIC insurance limit.

In November 2006, the Company entered into a license agreement with Cedars-Sinai Medical Center


Sponsored Research Agreements:
Aptiv Solutions
University of Pennsylvania
The John Hopkins University Licensing Agreement
The University of Pittsburgh Patent License Agreement

As of June 30, 2012, Warrants to purchase 4,110,992 shares of the Company’s common stock remain outstanding relating to this public offering.

Loss: We incurred a net loss of $6,451,817 and $1,550,825 for the three months ended June 30, 2012 and 2011, respectively.


GL